SPASFON, suppository 10 suppositories
Active ingredients: Anhydrous phloroglucinol, Phloroglucinol dihydrate, 1,3,5-trimethoxybenzene
Commercialized according to BDPM
Suppository10 suppositoriesrectale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SPASFON, suppositoire
- Pharmaceutical form
- suppositoire
- Route of administration
- rectale
- Presentation description
- plaquette(s) PVC de 10 suppositoire(s)
- Marketing authorisation holder
- ACINO (ALLEMAGNE)
- Reimbursement according to BDPM
- 15%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Douleurs liées à des troubles fonctionnels intestinaux<br>- Spasmes douloureux aiguës des voies urinaires : coliques néphrétiques<br>- Spasmes douloureux gynécologiques<br>- Spasmes douloureux au cours de la grossesse ; JOURNAL OFFICIEL ; 13/06/13
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Feb 1965
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65923640CIP73098614CIP133400930986141Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| PHLOROGLUCINOL DIHYDRATÉsuppositoire | 150,0 mg · un suppositoire | SA |
| TRIMÉTHYLPHLOROGLUCINOLsuppositoire | 150 mg · un suppositoire | SA |
| PHLOROGLUCINOL ANHYDREsuppositoire | 166,7 mg · un suppositoire | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.